Oral delivery of carrier-free dual-drug nanocrystal self-assembled microspheres improved NAD⁺ bioavailability and attenuated cardiac ischemia/reperfusion injury in mice

References

• Arpagaus C, Collenberg A, Rütti D, et al. (2018). Nano spray drying for encapsulation of pharmaceuticals. Int J Pharm 546:194–214.
   PubMed Web of Science ®Google Scholar
• Brown TD, Whitehead KA, Mitragotri S. (2020). Materials for oral delivery of proteins and peptides. Nat Rev Mater 5:127–48.
   Web of Science ®Google Scholar
• Cantó C, Houtkooper RH, Pirinen E, et al. (2012). The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 15:838–47.
   PubMed Web of Science ®Google Scholar
• Chiarugi A, Dölle C, Felici R, Ziegler M. (2012). The NAD metabolome-a key determinant of cancer cell biology. Nat Rev Cancer 12:741–52.
   PubMed Web of Science ®Google Scholar
• Diguet N, Trammell SAJ, Tannous C, et al. (2018). Nicotinamide riboside preserves cardiac function in a mouse model of dilated cardiomyopathy. Circulation 137:2256–73.
   PubMed Web of Science ®Google Scholar
• Elhassan YS, Kluckova K, Fletcher RS, et al. (2019). Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD + Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Rep 28:1717–28.
   PubMed Web of Science ®Google Scholar
• Fontana F, Figueiredo P, Zhang P, et al. (2018). Production of pure drug nanocrystals and nano co-crystals by confinement methods. Adv Drug Deliv Rev 131:3–21.
   PubMed Web of Science ®Google Scholar
• Garten A, Schuster S, Penke M, et al. (2015). Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol 11:535–46.
   PubMed Web of Science ®Google Scholar
• Grant R. (2010). Resveratrol increases intracellular NAD + levels through up regulation of the nad + synthetic enzyme nicotinamide mononucleotide adenylyltransferase. Nat. Prec 10(1):31–35.
   Google Scholar
• Griffin BT, Guo J, Presas E, et al. (2016). Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs. Adv Drug Deliv Rev 106:367–80.
   PubMed Web of Science ®Google Scholar
• Khan NA, Auranen M, Paetau I, et al. (2014). Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med 6:721–31.
   PubMed Web of Science ®Google Scholar
• Koushki M, Amiri-Dashatan N, Ahmadi N, et al. (2018). Resveratrol: a miraculous natural compound for diseases treatment. Food Sci Nutr 6:2473–90.
   PubMed Web of Science ®Google Scholar
• Lee CF, Chavez JD, Garcia-Menendez L, et al. (2016). Normalization of NAD+ redox balance as a therapy for heart failure. Circulation 134:883–94.
   PubMed Web of Science ®Google Scholar
• Liu L, Su X, Quinn WJ, et al. (2018). Quantitative analysis of NAD synthesis-breakdown fluxes. Cell Metab 27:1067–80. e1065.
   PubMed Web of Science ®Google Scholar
• Liu T, Yu X, Yin H, Möschwitzer JP. (2019). Advanced modification of drug nanocrystals by using novel fabrication and downstream approaches for tailor-made drug delivery. Drug Deliv 26:1092–103.
   PubMed Web of Science ®Google Scholar
• Li C, Wang J, Wang Y, et al. (2019). Recent progress in drug delivery. Acta Pharm Sin B 9:1145–62.
   PubMed Web of Science ®Google Scholar
• Li T, Zhang Z, Kolwicz SC, et al. (2017). Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury. Cell Metab 25:374–85.
   PubMed Web of Science ®Google Scholar
• Lu Y, Lv Y, Li T. (2019). Hybrid drug nanocrystals. Adv Drug Deliv Rev 143:115–33.
   PubMed Web of Science ®Google Scholar
• Martens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD + in healthy middle-aged and older adults. Nat Commun 9:1286.
   PubMed Web of Science ®Google Scholar
• Mathieu L, Lopes Costa A, Le Bachelier C, et al. (2016). Resveratrol attenuates oxidative stress in mitochondrial Complex I deficiency: involvement of SIRT3. Free Radic Biol Med 96:190–8.
   PubMed Web of Science ®Google Scholar
• Mohammad IS, Hu H, Yin L, He W. (2019). Drug nanocrystals: Fabrication methods and promising therapeutic applications. Int J Pharm 562:187–202.
   PubMedGoogle Scholar
• Mouchiroud L, Houtkooper RH, Auwerx J. (2013). NAD + metabolism: a therapeutic target for age-related metabolic disease. Crit Rev Biochem Mol Biol 48:397–408.
   PubMed Web of Science ®Google Scholar
• Novelle MG, Wahl D, Diéguez C, et al. (2015). Resveratrol supplementation: Where are we now and where should we go? Ageing Res Rev 21:1–15.
   PubMed Web of Science ®Google Scholar
• PA Ferreira M, Martins JP, Hirvonen J, Santos HA. 2020. Chapter 9 - Spray-drying for the formulation of oral drug delivery systems. In: Martins, J.P., Santos, H.A. (eds.), Nanotechnology for oral drug delivery. London: Academic Press, pp. 253–284.
   Google Scholar
• Peng J, Xiao Y, Yang Q, et al. (2020). Intracellular aggregation of peptide-reprogrammed small molecule nanoassemblies enhances cancer chemotherapy and combinatorial immunotherapy. Acta Pharm. Sin. B doi: 10.1016/j.apsb.2020.06.013
   Web of Science ®Google Scholar
• Peng J, Yang Q, Xiao Y, et al. (2019). Tumor microenvironment responsive drug-dye-peptide nanoassembly for enhanced tumor-targeting, penetration, and photo-chemo-immunotherapy. Adv Funct Mater 29:1900004.
   Web of Science ®Google Scholar
• Pham DT, Tiyaboonchai W. (2020). Fibroin nanoparticles: a promising drug delivery system. Drug Deliv 27:431–48.
   PubMed Web of Science ®Google Scholar
• Prysyazhna O, Wolhuter K, Switzer C, et al. (2019). Blood pressure-lowering by the antioxidant resveratrol is counterintuitively mediated by oxidation of cGMP-dependent protein kinase. Circulation 140:126–37.
   PubMed Web of Science ®Google Scholar
• Qi F, Wu J, Li H, Ma G. (2019). Recent research and development of PLGA/PLA microspheres/nanoparticles: A review in scientific and industrial aspects. Front Chem Sci Eng 13:14–27.
   Web of Science ®Google Scholar
• Neves AR, Lucio M, LC, Lima J, Reis S. (2012). Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Med Chem 19:1663–81.
   PubMed Web of Science ®Google Scholar
• Rajman L, Chwalek K, Sinclair DA. (2018). Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab 27:529–47.
   PubMed Web of Science ®Google Scholar
• Ribeiro AM, Veiga F, Figueiras A. 2017. Chapter 3 - Biodegradable polymeric nanostructures: design and advances in oral drug delivery for neurodegenerative disorders, In: Andronescu, E., Grumezescu, A.M. (Eds.), Nanostructures for Oral Medicine. Elsevier, pp. 61–86.
   Google Scholar
• Schöndorf DC, Ivanyuk D, Baden P, et al. (2018). The NAD + precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson's disease. Cell Rep 23:2976–88.
   PubMed Web of Science ®Google Scholar
• Sheikhpour M, Barani L, Kasaeian A. (2017). Biomimetics in drug delivery systems: A critical review. J Control Release 253:97–109.
   PubMed Web of Science ®Google Scholar
• Sim T, Lim C, Hoang NH, et al. (2016). Nanomedicines for oral administration based on diverse nanoplatform. J. Pharm. Investig 46:351–62.
   Google Scholar
• Sosnik A, Augustine R. (2016). Challenges in oral drug delivery of antiretrovirals and the innovative strategies to overcome them. Adv Drug Deliv Rev 103:105–20.
   PubMed Web of Science ®Google Scholar
• Sverdlov Arzi R, Sosnik A. (2018). Electrohydrodynamic atomization and spray-drying for the production of pure drug nanocrystals and co-crystals. Adv Drug Deliv Rev 131:79–100.
   PubMed Web of Science ®Google Scholar
• Trammell SAJ, Schmidt MS, Weidemann BJ, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun 7:12948
   PubMed Web of Science ®Google Scholar
• Viswanathan P, Muralidaran Y, Ragavan G. 2017. Chapter 7 – Challenges in oral drug delivery: a nano-based strategy to overcome, In: Andronescu, E., Grumezescu, A.M. (Eds.), Nanostructures for oral medicine. Elsevier, pp. 173–201.
   Google Scholar
• Wang W, Karamanlidis G, Tian R. (2016). Novel targets for mitochondrial medicine. Sci Transl Med 8:326rv3–326rv323.
   PubMed Web of Science ®Google Scholar
• Yang SJ, Choi JM, Kim L, et al. (2014). Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes. J Nutr Biochem 25:66–72.
   PubMed Web of Science ®Google Scholar
• Yang H, Kim H, Jung S, et al. (2018). Pharmaceutical strategies for stabilizing drug nanocrystals. Curr Pharm Des 24:2362–74.
   PubMed Web of Science ®Google Scholar
• Yang Q, Xiao Y, Liu Q, et al. (2020). Carrier-free small-molecule drug nanoassembly elicits chemoimmunotherapy via co-inhibition of PD-L1/mTOR. ACS Appl Bio Mater 3:4543–55.
   PubMedGoogle Scholar
• Yang Q, Xiao Y, Yin Y, et al. (2019). Erythrocyte membrane-camouflaged IR780 and DTX coloading polymeric nanoparticles for imaging-guided cancer photo-chemo combination therapy. Mol Pharm 16:3208–20.
   PubMed Web of Science ®Google Scholar
• Yin Y, Yuan X, Gao H, Yang Q. (2020). Nanoformulations of small molecule protein tyrosine kinases inhibitors potentiate targeted cancer therapy. Int J Pharm 573:118785.
   PubMedGoogle Scholar